Halozyme Therapeutics, Inc. (HALO)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
9.94+0.14 (+1.43%)
As of 12:16 PM EDT. Market open.
People also watch:
ZIOPFOLDCLDXACADACHN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open9.78
Prev Close9.80
Bid9.91 x 700
Ask9.92 x 300
Day's Range9.72 - 9.99
52wk Range6.96 - 19.63
1y Target EstN/A
Market Cap1.28B
P/E Ratio (ttm)-18.97
Beta2.03
Volume280,815
Avg Vol (3m)1,330,537
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cubeyesterday

    ETF’s with exposure to Halozyme Therapeutics, Inc. : August 29, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Halozyme Therapeutics, Inc. Here are 5 ETF’s with the largest exposure to HALO-US. Comparing the performance and risk of Halozyme Therapeutics, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube15 days ago

    ETF’s with exposure to Halozyme Therapeutics, Inc. : August 15, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Halozyme Therapeutics, Inc. Here are 5 ETF’s with the largest exposure to HALO-US. Comparing the performance and risk of Halozyme Therapeutics, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Halozyme Therapeutics, Inc. :HALO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
    Capital Cube18 days ago

    Halozyme Therapeutics, Inc. :HALO-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016

    Categories: Yahoo Finance Click here to see latest analysis Halozyme Therapeutics, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Halozyme Therapeutics, Inc. – MannKind Corporation, Eli Lilly and Company, Baxter International Inc., Intrexon Corporation, Pfizer Inc. and Johnson & Johnson (MNKD-US, LLY-US, BAX-US, XON-US, PFE-US ... Read more (Read more...)